1. Home
  2. LBGJ vs BOLD Comparison

LBGJ vs BOLD Comparison

Compare LBGJ & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBGJ
  • BOLD
  • Stock Information
  • Founded
  • LBGJ 2007
  • BOLD 2018
  • Country
  • LBGJ China
  • BOLD United States
  • Employees
  • LBGJ N/A
  • BOLD N/A
  • Industry
  • LBGJ
  • BOLD
  • Sector
  • LBGJ
  • BOLD
  • Exchange
  • LBGJ NYSE
  • BOLD Nasdaq
  • Market Cap
  • LBGJ 24.7M
  • BOLD 24.4M
  • IPO Year
  • LBGJ 2024
  • BOLD 2024
  • Fundamental
  • Price
  • LBGJ $1.42
  • BOLD $1.21
  • Analyst Decision
  • LBGJ
  • BOLD Buy
  • Analyst Count
  • LBGJ 0
  • BOLD 3
  • Target Price
  • LBGJ N/A
  • BOLD $4.00
  • AVG Volume (30 Days)
  • LBGJ 24.7K
  • BOLD 280.0K
  • Earning Date
  • LBGJ 08-15-2025
  • BOLD 08-11-2025
  • Dividend Yield
  • LBGJ N/A
  • BOLD N/A
  • EPS Growth
  • LBGJ N/A
  • BOLD N/A
  • EPS
  • LBGJ N/A
  • BOLD N/A
  • Revenue
  • LBGJ $11,781,015.00
  • BOLD N/A
  • Revenue This Year
  • LBGJ N/A
  • BOLD N/A
  • Revenue Next Year
  • LBGJ N/A
  • BOLD N/A
  • P/E Ratio
  • LBGJ N/A
  • BOLD N/A
  • Revenue Growth
  • LBGJ 21.82
  • BOLD N/A
  • 52 Week Low
  • LBGJ $1.02
  • BOLD $1.00
  • 52 Week High
  • LBGJ $5.50
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • LBGJ N/A
  • BOLD N/A
  • Support Level
  • LBGJ N/A
  • BOLD N/A
  • Resistance Level
  • LBGJ N/A
  • BOLD N/A
  • Average True Range (ATR)
  • LBGJ 0.00
  • BOLD 0.00
  • MACD
  • LBGJ 0.00
  • BOLD 0.00
  • Stochastic Oscillator
  • LBGJ 0.00
  • BOLD 0.00

About LBGJ LI BANG INTERNATIONAL CORPORATION I

Li Bang International Corp Inc is a holding company. The firm through its subsidiaries engages in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China under its own Libang brand. In addition, its subsidiaries provide customers with comprehensive services, from commercial kitchen design in the early stage to equipment installation and after-sales maintenance.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: